摘要:
The invention relates to the method of preparing catalyst based on platinum (Pt), with a low Pt content, dispersed on carrier containing graphene quantum dots (Pt/GQDs or Pt/GO-GQDs) used for fuel cell with excellent activity in the electrochemical oxidation reaction of alcohol (for example, methanol, ethanol), applied as an anode catalyst for direct alcohol fuel cell (DAFC). At the same time, the invention also refers to the catalyst obtained by this method as an anode catalyst for DAFC.
摘要:
The invention relates to the method of preparing catalyst based on platinum (Pt), with a low Pt content, dispersed on carrier containing graphene quantum dots (Pt/GQDs or Pt/GO-GQDs) used for fuel cell with excellent activity in the electrochemical oxidation reaction of alcohol (for example, methanol, ethanol), applied as an anode catalyst for direct alcohol fuel cell (DAFC). At the same time, the invention also refers to the catalyst obtained by this method as an anode catalyst for DAFC.
摘要:
The present invention relates to purified and isolated DNA sequences having protein production increasing activity and more specifically to the use of matrix attachment regions (MARs) for increasing protein production activity in a eukaryotic cell. Also disclosed is a method for the identification of said active regions, in particular MAR nucleotide sequences, and the use of these characterized active MAR sequences in a new multiple transfection method.
摘要:
Trientine prodrugs, pharmaceutical compositions comprising the trientine prodrugs, and methods of using trientine prodrugs and pharmaceutical compositions thereof for treating Wilson's disease.
摘要:
Cysteine, N-acetylcysteine, and penicillamine related compounds, pharmaceutical compositions comprising the cysteine, N-acetylcysteine, and penicillamine related compounds, and methods of using cysteine, N-acetylcysteine, and penicillamine related compounds and pharmaceutical compositions thereof for treating liver, kidney, lung, neurological, inflammatory, and autoimmune disorders including paracetamol overdose, non-alcoholic steatohepatitis, Wilson's disease, cystinuria, irritable bowel disorder, ulcerative colitis, rheumatoid arthritis, chronic obstructive pulmonary disease, interstitial lung disease, asthma, cystic fibrosis, Parkinson's disease, and Huntington's disease.
摘要:
Cysteine, N-acetylcysteine, and penicillamine related compounds, pharmaceutical compositions comprising the cysteine, N-acetylcysteine, and penicillamine related compounds, and methods of using cysteine, N-acetylcysteine, and penicillamine related compounds and pharmaceutical compositions thereof for treating liver, kidney, lung, neurological, inflammatory, and autoimmune disorders including paracetamol overdose, non-alcoholic steatohepatitis, Wilson's disease, cystinuria, irritable bowel disorder, ulcerative colitis, rheumatoid arthritis, chronic obstructive pulmonary disease, interstitial lung disease, asthma, cystic fibrosis, Parkinson's disease, and Huntington's disease.
摘要:
Fumarate compounds, pharmaceutical compositions comprising the fumarate compounds, and methods of using fumarate compounds and pharmaceutical compositions for treating neurodegenerative, inflammatory, and autoimmune disorders including multiple sclerosis, psoriasis, irritable bowel disorder, ulcerative colitis, arthritis, chronic obstructive pulmonary disease, asthma, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are disclosed.
摘要:
Fumarate compounds, pharmaceutical compositions comprising the fumarate compounds, and methods of using fumarate compounds and pharmaceutical compositions for treating neurodegenerative, inflammatory, and autoimmune disorders including multiple sclerosis, psoriasis, irritable bowel disorder, ulcerative colitis, arthritis, chronic obstructive pulmonary disease, asthma, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are disclosed.
摘要:
The invention may provide a temperature sensor device that includes an analog temperature sensor to generate a first base-emitter voltage and a second base-emitter voltage, and an analog-to-digital converter (ADC) to sample at the voltages and generate corresponding digital values. The temperature sensor device may also include a logic unit to calculate a digital temperature code from the digital values using a digital virtual reference.